Does INVAGEN PHARMACEUTICALS, INC sponsor green cards?

INVAGEN PHARMACEUTICALS, INC has 71 PERM (green-card) filings with the U.S. Department of Labor based on public disclosure data.

How many H-1B visas does INVAGEN PHARMACEUTICALS, INC sponsor?

INVAGEN PHARMACEUTICALS, INC has 472 LCA (work-visa) filings, the Department of Labor step before an H-1B or other non-immigrant worker petition to USCIS.

How long has INVAGEN PHARMACEUTICALS, INC been filing with the U.S. Department of Labor?

Public DOL records for INVAGEN PHARMACEUTICALS, INC cover fiscal years 2008 through 2026.

INVAGEN PHARMACEUTICALS, INC

71 Green card sponsorships · 472 Temporary work filings · Manufacturing · FY2008–FY2026

332 Total employees Self-reported on green-card filings · FY2025

71 Green-card filings PERM PERM — Permanent Employment Certification (ETA-9089) Employer's DOL filing to sponsor a specific worker for an employment-based green card after testing the U.S. job marketTemporary visa (often F-1 student → H-1B)PERM — employer asks DOL to certify the jobI-140 — employer petitions USCISPriority-date wait (varies by country of birth — years to decades)Green card (I-485 / consular)DOL certifies paperwork — it does not issue green cards; per-position; certified ≠ granted. NEVER "work permit"Common path — some categories skip PERM (EB-1, NIW); timelines vary widely by country of birth. Educational info, not legal advice.Official source ↗ filings on record

472 Work-visa filings LCA LCA — Labor Condition Application (ETA-9035) Employer's legally binding wage promise to DOL, required before employing H-1B/H-1B1/E-3 workersJob offer + prevailing wageLCA — wage promise to DOLCap lottery registration (USCIS)I-129 petition (USCIS)Visa issued / status changed (DOS or USCIS)One filing can cover MANY positions — filing counts ≠ worker counts (employers over-file for lottery/relocations); not a visaCommon path — some categories skip PERM (EB-1, NIW); timelines vary widely by country of birth. Educational info, not legal advice.Official source ↗ filings on record

$86,000 Median offered wage FY2016 n=17 PERM PERM — Permanent Employment Certification (ETA-9089) Employer's DOL filing to sponsor a specific worker for an employment-based green card after testing the U.S. job marketTemporary visa (often F-1 student → H-1B)PERM — employer asks DOL to certify the jobI-140 — employer petitions USCISPriority-date wait (varies by country of birth — years to decades)Green card (I-485 / consular)DOL certifies paperwork — it does not issue green cards; per-position; certified ≠ granted. NEVER "work permit"Common path — some categories skip PERM (EB-1, NIW); timelines vary widely by country of birth. Educational info, not legal advice.Official source ↗ filings · Chemists (19-2031)

What this means for you

One record, five questions. Ask as many as you like.

Colors from an applicant's view: green = better than most employers in its industry, red = worse, gray = about the same or too few filings

Showing 3 of 17 measurement rows
Manufacturing · est. 332 U.S. employees
Work-visa filings, FY2025 vs FY2024⁠Work-visa filings, FY2025 vs FY2024INVAGEN PHARMACEUTICALS, INC = +80%: its work-visa filings, FY2025 (36) against FY2024 (20).Manufacturing = +17%: all Manufacturing employers' work-visa filings, FY2025 against FY2024 (pooled).All U.S. = +8%: every U.S. employer's work-visa filings, FY2025 against FY2024 (pooled).Rank and percentile: its change among employers with 20+ work-visa filings in both FY2024 and FY2025, in its industry and in the U.S. — Tied #14 with 1 other of 272 in Manufacturing · Tied #185 with 3 others of 2,839 in U.S..Source: DOL disclosure dataOfficial source ↗ +80%INVAGEN PHARMACEUTICALS, INC +17%Manufacturing +8%All U.S. Tied #14 with 1 other of 272 in Manufacturing Tied #185 with 3 others of 2,839 in U.S. Rank Top 6% of Manufacturing Top 7% of U.S. Percentile 36 vs 20 filings · FY2025 vs FY2024

Green-card filings, FY2025 vs FY2024⁠Green-card filings, FY2025 vs FY2024INVAGEN PHARMACEUTICALS, INC = 0%: its green-card filings, FY2025 (2) against FY2024 (2).Manufacturing = +74%: all Manufacturing employers' green-card filings, FY2025 against FY2024 (pooled).All U.S. = +60%: every U.S. employer's green-card filings, FY2025 against FY2024 (pooled).Rank and percentile: its change among employers with 20+ green-card filings in both FY2024 and FY2025, in its industry and in the U.S. — Not ranked: under 20 filings in FY2024 or FY2025 (2 and 2).Source: DOL disclosure dataOfficial source ↗ 0%INVAGEN PHARMACEUTICALS, INC +74%Manufacturing +60%All U.S. Not ranked: under 20 filings in FY2024 or FY2025 (2 and 2) Not ranked: under 20 filings in FY2024 or FY2025 (2 and 2) Rank Not ranked: under 20 filings in FY2024 or FY2025 (2 and 2) Not ranked: under 20 filings in FY2024 or FY2025 (2 and 2) Percentile 2 vs 2 filings · FY2025 vs FY2024

Work-visa filings per 100 employees⁠Work-visa filings per 100 employeesINVAGEN PHARMACEUTICALS, INC = 7.0: each year's work-visa filings over that year's reported headcount, per 100 employees, mean of 2 years, FY2024 and FY2025; FY2025 alone: 11.Manufacturing = 1.3: the median of 623 ranked Manufacturing employers' rates, per 100 employees.All U.S. = 4.8: the median of 5,111 ranked U.S. employers' rates, per 100 employees.Rank and percentile: its rate among employers with 20+ filings and a reported headcount, in its industry and in the U.S. — #91 of 623 in Manufacturing · #2,274 of 5,111 in U.S..Source: DOL filings vs self-reported headcountOfficial source ↗ 7.0INVAGEN PHARMACEUTICALS, INC 1.3Manufacturing 4.8All U.S. #91 of 623 in Manufacturing #2,274 of 5,111 in U.S. Rank Top 15% of Manufacturing Top 45% of U.S. Percentile 64 filings · mean of 2 years, FY2024 and FY2025 · last filing FY2026
Layoff notices are withheld from this panel (WARN coverage 35.7% of 255 state-year cells < 60%) → see the WARN notices tab. Coverage gate
History, not a hiring promise.

Showing 5 of 17 measurement rows
Manufacturing · est. 332 U.S. employees
Green-card filings per 100 employees⁠Green-card filings per 100 employeesINVAGEN PHARMACEUTICALS, INC = —: 4 green-card filings in FY2023-25 and no per-employee rate (4 green-card filings in FY2023-FY2025, under the 20-filing floor).Manufacturing = 0.69: the median of 247 ranked Manufacturing employers' rates, per 100 employees.All U.S. = 1.9: the median of 1,693 ranked U.S. employers' rates, per 100 employees.Rank and percentile: its rate among employers with 20+ filings and a reported headcount, in its industry and in the U.S. — Not ranked: 4 green-card filings in FY2023-FY2025, under the 20-filing floor.Source: DOL filings vs self-reported headcountOfficial source ↗ —INVAGEN PHARMACEUTICALS, INC 0.69Manufacturing 1.9All U.S. Not ranked: 4 green-card filings in FY2023-FY2025, under the 20-filing floor Not ranked: 4 green-card filings in FY2023-FY2025, under the 20-filing floor Rank Not ranked: 4 green-card filings in FY2023-FY2025, under the 20-filing floor Not ranked: 4 green-card filings in FY2023-FY2025, under the 20-filing floor Percentile 4 filings · FY2023-25 · last filing FY2026

Green cards certified⁠Green cards certifiedINVAGEN PHARMACEUTICALS, INC = 100.0%: 4 of its 4 green-card filings certified, FY2023-25.Manufacturing = 93.2%: all Manufacturing employers' green-card filings certified, over all their green-card filings, FY2023-25 (pooled).All U.S. = 91.6%: every U.S. employer's green-card filings certified, over all their green-card filings, FY2023-25 (pooled).Rank and percentile: its share among employers with 20+ green-card filings in FY2023-25, in its industry and in the U.S. — Not ranked: under 20 filings (4).Source: DOL PERM disclosure dataOfficial source ↗ 100.0%INVAGEN PHARMACEUTICALS, INC 93.2%Manufacturing 91.6%All U.S. Not ranked: under 20 filings (4) Not ranked: under 20 filings (4) Rank Not ranked: under 20 filings (4) Not ranked: under 20 filings (4) Percentile 4 of 4 filings · FY2023-25

Green cards denied⁠Green cards deniedINVAGEN PHARMACEUTICALS, INC = 0.0%: 0 of its 4 green-card filings denied, FY2023-25.Manufacturing = 2.2%: all Manufacturing employers' green-card filings denied, over all their green-card filings, FY2023-25 (pooled).All U.S. = 4.1%: every U.S. employer's green-card filings denied, over all their green-card filings, FY2023-25 (pooled).Rank and percentile: its share among employers with 20+ green-card filings in FY2023-25, in its industry and in the U.S. — Not ranked: under 20 filings (4).Source: DOL PERM disclosure dataOfficial source ↗ 0.0%INVAGEN PHARMACEUTICALS, INC 2.2%Manufacturing 4.1%All U.S. Not ranked: under 20 filings (4) Not ranked: under 20 filings (4) Rank Not ranked: under 20 filings (4) Not ranked: under 20 filings (4) Percentile 0 of 4 filings · FY2023-25

Green-card filings, FY2025 vs FY2024⁠Green-card filings, FY2025 vs FY2024INVAGEN PHARMACEUTICALS, INC = 0%: its green-card filings, FY2025 (2) against FY2024 (2).Manufacturing = +74%: all Manufacturing employers' green-card filings, FY2025 against FY2024 (pooled).All U.S. = +60%: every U.S. employer's green-card filings, FY2025 against FY2024 (pooled).Rank and percentile: its change among employers with 20+ green-card filings in both FY2024 and FY2025, in its industry and in the U.S. — Not ranked: under 20 filings in FY2024 or FY2025 (2 and 2).Source: DOL disclosure dataOfficial source ↗ 0%INVAGEN PHARMACEUTICALS, INC +74%Manufacturing +60%All U.S. Not ranked: under 20 filings in FY2024 or FY2025 (2 and 2) Not ranked: under 20 filings in FY2024 or FY2025 (2 and 2) Rank Not ranked: under 20 filings in FY2024 or FY2025 (2 and 2) Not ranked: under 20 filings in FY2024 or FY2025 (2 and 2) Percentile 2 vs 2 filings · FY2025 vs FY2024

Median wage, Chemists⁠Median wage, ChemistsINVAGEN PHARMACEUTICALS, INC = $75,639: the median annual prevailing wage of its green-card filings for Chemists (19-2031), FY2008–FY2026.Manufacturing = $75,878: the median of every Manufacturing employer's green-card filings for the same occupation, all years (pooled).All U.S. = $73,195: the median of every U.S. employer's green-card filings for the same occupation, all years (pooled).Rank and percentile: its median among employers with 20+ green-card filings for this occupation, in its industry and in the U.S.; #1 is the highest pay — Too few U.S. employers to rank (16).Source: DOL prevailing-wage data · FY2008–FY2026Official source ↗ $75,639INVAGEN PHARMACEUTICALS, INC $75,878Manufacturing $73,195All U.S. Too few Manufacturing employers to rank (12) Too few U.S. employers to rank (16) Rank Too few Manufacturing employers to rank (12) Too few U.S. employers to rank (16) Percentile 42 filings with a prevailing wage · FY2008–FY2026
History, not a hiring promise.

Showing 4 of 17 measurement rows
Manufacturing · est. 332 U.S. employees
Work-visa filings per 100 employees⁠Work-visa filings per 100 employeesINVAGEN PHARMACEUTICALS, INC = 7.0: each year's work-visa filings over that year's reported headcount, per 100 employees, mean of 2 years, FY2024 and FY2025; FY2025 alone: 11.Manufacturing = 1.3: the median of 623 ranked Manufacturing employers' rates, per 100 employees.All U.S. = 4.8: the median of 5,111 ranked U.S. employers' rates, per 100 employees.Rank and percentile: its rate among employers with 20+ filings and a reported headcount, in its industry and in the U.S. — #91 of 623 in Manufacturing · #2,274 of 5,111 in U.S..Source: DOL filings vs self-reported headcountOfficial source ↗ 7.0INVAGEN PHARMACEUTICALS, INC 1.3Manufacturing 4.8All U.S. #91 of 623 in Manufacturing #2,274 of 5,111 in U.S. Rank Top 15% of Manufacturing Top 45% of U.S. Percentile 64 filings · mean of 2 years, FY2024 and FY2025 · last filing FY2026

Work visas certified⁠Work visas certifiedINVAGEN PHARMACEUTICALS, INC = 95.3%: 61 of its 64 work-visa filings certified, FY2023-25.Manufacturing = 93.4%: all Manufacturing employers' work-visa filings certified, over all their work-visa filings, FY2023-25 (pooled).All U.S. = 91.9%: every U.S. employer's work-visa filings certified, over all their work-visa filings, FY2023-25 (pooled).Rank and percentile: its share among employers with 20+ work-visa filings in FY2023-25, in its industry and in the U.S. — #429 of 841 in Manufacturing · Tied #5,176 with 3 others of 9,738 in U.S..Source: DOL LCA disclosure data, case statusOfficial source ↗ 95.3%INVAGEN PHARMACEUTICALS, INC 93.4%Manufacturing 91.9%All U.S. #429 of 841 in Manufacturing Tied #5,176 with 3 others of 9,738 in U.S. Rank Bottom 50% of Manufacturing Bottom 47% of U.S. Percentile 61 of 64 filings · FY2023-25

USCIS H-1B petitions approved⁠USCIS H-1B petitions approvedINVAGEN PHARMACEUTICALS, INC = 96%: 23 of its 24 decided H-1B petitions approved, initial and continuing, FY2022-23.Manufacturing = 98.0%: all Manufacturing employers' approved petitions over all their decided petitions, initial and continuing, FY2022-23 (pooled).All U.S. = 97.6%: every U.S. employer's approved petitions over all their decided petitions, initial and continuing, FY2022-23 (pooled).Rank and percentile: its approval share among employers with 20+ decided petitions in FY2022-23, in its industry and in the U.S. — Tied #284 with 1 other of 333 in Manufacturing · Tied #2,350 with 29 others of 2,993 in U.S..Source: U.S. Citizenship and Immigration Services H-1B Employer Data Hub · FY2022-FY2023 · initial and continuing petitionsOfficial source ↗ 96%INVAGEN PHARMACEUTICALS, INC 98.0%Manufacturing 97.6%All U.S. Tied #284 with 1 other of 333 in Manufacturing Tied #2,350 with 29 others of 2,993 in U.S. Rank Bottom 16% of Manufacturing Bottom 22% of U.S. Percentile 23 of 24 petitions decided · FY2022-23

Work-visa filings, FY2025 vs FY2024⁠Work-visa filings, FY2025 vs FY2024INVAGEN PHARMACEUTICALS, INC = +80%: its work-visa filings, FY2025 (36) against FY2024 (20).Manufacturing = +17%: all Manufacturing employers' work-visa filings, FY2025 against FY2024 (pooled).All U.S. = +8%: every U.S. employer's work-visa filings, FY2025 against FY2024 (pooled).Rank and percentile: its change among employers with 20+ work-visa filings in both FY2024 and FY2025, in its industry and in the U.S. — Tied #14 with 1 other of 272 in Manufacturing · Tied #185 with 3 others of 2,839 in U.S..Source: DOL disclosure dataOfficial source ↗ +80%INVAGEN PHARMACEUTICALS, INC +17%Manufacturing +8%All U.S. Tied #14 with 1 other of 272 in Manufacturing Tied #185 with 3 others of 2,839 in U.S. Rank Top 6% of Manufacturing Top 7% of U.S. Percentile 36 vs 20 filings · FY2025 vs FY2024
History, not a hiring promise.

Showing 4 of 17 measurement rows
Manufacturing · est. 332 U.S. employees
Work-visa filings, FY2025 vs FY2024⁠Work-visa filings, FY2025 vs FY2024INVAGEN PHARMACEUTICALS, INC = +80%: its work-visa filings, FY2025 (36) against FY2024 (20).Manufacturing = +17%: all Manufacturing employers' work-visa filings, FY2025 against FY2024 (pooled).All U.S. = +8%: every U.S. employer's work-visa filings, FY2025 against FY2024 (pooled).Rank and percentile: its change among employers with 20+ work-visa filings in both FY2024 and FY2025, in its industry and in the U.S. — Tied #258 with 1 other of 272 in Manufacturing · Tied #2,652 with 3 others of 2,839 in U.S..Source: DOL disclosure dataOfficial source ↗ +80%INVAGEN PHARMACEUTICALS, INC +17%Manufacturing +8%All U.S. Tied #258 with 1 other of 272 in Manufacturing Tied #2,652 with 3 others of 2,839 in U.S. Rank Bottom 6% of Manufacturing Bottom 7% of U.S. Percentile 36 vs 20 filings · FY2025 vs FY2024

Green-card filings, FY2025 vs FY2024⁠Green-card filings, FY2025 vs FY2024INVAGEN PHARMACEUTICALS, INC = 0%: its green-card filings, FY2025 (2) against FY2024 (2).Manufacturing = +74%: all Manufacturing employers' green-card filings, FY2025 against FY2024 (pooled).All U.S. = +60%: every U.S. employer's green-card filings, FY2025 against FY2024 (pooled).Rank and percentile: its change among employers with 20+ green-card filings in both FY2024 and FY2025, in its industry and in the U.S. — Not ranked: under 20 filings in FY2024 or FY2025 (2 and 2).Source: DOL disclosure dataOfficial source ↗ 0%INVAGEN PHARMACEUTICALS, INC +74%Manufacturing +60%All U.S. Not ranked: under 20 filings in FY2024 or FY2025 (2 and 2) Not ranked: under 20 filings in FY2024 or FY2025 (2 and 2) Rank Not ranked: under 20 filings in FY2024 or FY2025 (2 and 2) Not ranked: under 20 filings in FY2024 or FY2025 (2 and 2) Percentile 2 vs 2 filings · FY2025 vs FY2024

Median wage, Chemists⁠Median wage, ChemistsINVAGEN PHARMACEUTICALS, INC = $75,639: the median annual prevailing wage of its green-card filings for Chemists (19-2031), FY2008–FY2026.Manufacturing = $75,878: the median of every Manufacturing employer's green-card filings for the same occupation, all years (pooled).All U.S. = $73,195: the median of every U.S. employer's green-card filings for the same occupation, all years (pooled).Rank and percentile: its median among employers with 20+ green-card filings for this occupation, in its industry and in the U.S.; #1 is the highest pay — Too few U.S. employers to rank (16).Source: DOL prevailing-wage data · FY2008–FY2026Official source ↗ $75,639INVAGEN PHARMACEUTICALS, INC $75,878Manufacturing $73,195All U.S. Too few Manufacturing employers to rank (12) Too few U.S. employers to rank (16) Rank Too few Manufacturing employers to rank (12) Too few U.S. employers to rank (16) Percentile 42 filings with a prevailing wage · FY2008–FY2026

Temp-to-perm⁠Temp-to-permINVAGEN PHARMACEUTICALS, INC = 6.6:1: its 472 work-visa filings over its 71 green-card filings, FY2008–FY2026.Manufacturing = 2.8:1: all Manufacturing employers' work-visa filings over their green-card filings, all years (pooled).All U.S. = 5.4:1: every U.S. employer's work-visa filings over their green-card filings, all years (pooled).Rank and percentile: its ratio among employers with 20+ green-card filings, in its industry and in the U.S.; #1 is the lowest ratio — #1,087 of 1,182 in Manufacturing · #6,662 of 9,248 in U.S..Source: DOL disclosure dataOfficial source ↗ 6.6:1INVAGEN PHARMACEUTICALS, INC 2.8:1Manufacturing 5.4:1All U.S. #1,087 of 1,182 in Manufacturing #6,662 of 9,248 in U.S. Rank Bottom 9% of Manufacturing Bottom 28% of U.S. Percentile 472 work visas / 71 green cards · FY2008–FY2026
Layoff notices are withheld from this panel (WARN coverage 35.7% of 255 state-year cells < 60%) → see the WARN notices tab. Coverage gate
History, not a hiring promise.

Showing 14 of 17 measurement rows
Work visas denied⁠Work visas deniedINVAGEN PHARMACEUTICALS, INC = 0.0%: 0 of its 64 work-visa filings denied, FY2023-25.Manufacturing = 0.2%: all Manufacturing employers' work-visa filings denied, over all their work-visa filings, FY2023-25 (pooled).All U.S. = 0.7%: every U.S. employer's work-visa filings denied, over all their work-visa filings, FY2023-25 (pooled).Rank and percentile: its share among employers with 20+ work-visa filings in FY2023-25, in its industry and in the U.S. — Tied #1 with 705 others of 841 in Manufacturing · Tied #1 with 8,462 others of 9,738 in U.S..Source: DOL LCA disclosure data, case statusOfficial source ↗ 0.0%INVAGEN PHARMACEUTICALS, INC 0.2%Manufacturing 0.7%All U.S. Tied #1 with 705 others of 841 in Manufacturing Tied #1 with 8,462 others of 9,738 in U.S. Rank Tied with 84% of Manufacturing Tied with 87% of U.S. Percentile 0 of 64 filings · FY2023-25

Green cards denied⁠Green cards deniedINVAGEN PHARMACEUTICALS, INC = 0.0%: 0 of its 4 green-card filings denied, FY2023-25.Manufacturing = 2.2%: all Manufacturing employers' green-card filings denied, over all their green-card filings, FY2023-25 (pooled).All U.S. = 4.1%: every U.S. employer's green-card filings denied, over all their green-card filings, FY2023-25 (pooled).Rank and percentile: its share among employers with 20+ green-card filings in FY2023-25, in its industry and in the U.S. — Not ranked: under 20 filings (4).Source: DOL PERM disclosure dataOfficial source ↗ 0.0%INVAGEN PHARMACEUTICALS, INC 2.2%Manufacturing 4.1%All U.S. Not ranked: under 20 filings (4) Not ranked: under 20 filings (4) Rank Not ranked: under 20 filings (4) Not ranked: under 20 filings (4) Percentile 0 of 4 filings · FY2023-25

Work visas certified⁠Work visas certifiedINVAGEN PHARMACEUTICALS, INC = 95.3%: 61 of its 64 work-visa filings certified, FY2023-25.Manufacturing = 93.4%: all Manufacturing employers' work-visa filings certified, over all their work-visa filings, FY2023-25 (pooled).All U.S. = 91.9%: every U.S. employer's work-visa filings certified, over all their work-visa filings, FY2023-25 (pooled).Rank and percentile: its share among employers with 20+ work-visa filings in FY2023-25, in its industry and in the U.S. — #429 of 841 in Manufacturing · Tied #5,176 with 3 others of 9,738 in U.S..Source: DOL LCA disclosure data, case statusOfficial source ↗ 95.3%INVAGEN PHARMACEUTICALS, INC 93.4%Manufacturing 91.9%All U.S. #429 of 841 in Manufacturing Tied #5,176 with 3 others of 9,738 in U.S. Rank Bottom 50% of Manufacturing Bottom 47% of U.S. Percentile 61 of 64 filings · FY2023-25

Green cards certified⁠Green cards certifiedINVAGEN PHARMACEUTICALS, INC = 100.0%: 4 of its 4 green-card filings certified, FY2023-25.Manufacturing = 93.2%: all Manufacturing employers' green-card filings certified, over all their green-card filings, FY2023-25 (pooled).All U.S. = 91.6%: every U.S. employer's green-card filings certified, over all their green-card filings, FY2023-25 (pooled).Rank and percentile: its share among employers with 20+ green-card filings in FY2023-25, in its industry and in the U.S. — Not ranked: under 20 filings (4).Source: DOL PERM disclosure dataOfficial source ↗ 100.0%INVAGEN PHARMACEUTICALS, INC 93.2%Manufacturing 91.6%All U.S. Not ranked: under 20 filings (4) Not ranked: under 20 filings (4) Rank Not ranked: under 20 filings (4) Not ranked: under 20 filings (4) Percentile 4 of 4 filings · FY2023-25

USCIS H-1B petitions approved⁠USCIS H-1B petitions approvedINVAGEN PHARMACEUTICALS, INC = 96%: 23 of its 24 decided H-1B petitions approved, initial and continuing, FY2022-23.Manufacturing = 98.0%: all Manufacturing employers' approved petitions over all their decided petitions, initial and continuing, FY2022-23 (pooled).All U.S. = 97.6%: every U.S. employer's approved petitions over all their decided petitions, initial and continuing, FY2022-23 (pooled).Rank and percentile: its approval share among employers with 20+ decided petitions in FY2022-23, in its industry and in the U.S. — Tied #284 with 1 other of 333 in Manufacturing · Tied #2,350 with 29 others of 2,993 in U.S..Source: U.S. Citizenship and Immigration Services H-1B Employer Data Hub · FY2022-FY2023 · initial and continuing petitionsOfficial source ↗ 96%INVAGEN PHARMACEUTICALS, INC 98.0%Manufacturing 97.6%All U.S. Tied #284 with 1 other of 333 in Manufacturing Tied #2,350 with 29 others of 2,993 in U.S. Rank Bottom 16% of Manufacturing Bottom 22% of U.S. Percentile 23 of 24 petitions decided · FY2022-23

Work visas certified, then withdrawn⁠Work visas certified, then withdrawnINVAGEN PHARMACEUTICALS, INC = 4.7%: 3 of its 64 work-visa filings certified, then withdrawn, FY2023-25.Manufacturing = 5.2%: all Manufacturing employers' work-visa filings certified, then withdrawn, over all their work-visa filings, FY2023-25 (pooled).All U.S. = 5.8%: every U.S. employer's work-visa filings certified, then withdrawn, over all their work-visa filings, FY2023-25 (pooled).Rank and percentile: its share among employers with 20+ work-visa filings in FY2023-25, in its industry and in the U.S. — Not ranked for this question.Source: DOL LCA disclosure data, case statusOfficial source ↗ 4.7%INVAGEN PHARMACEUTICALS, INC 5.2%Manufacturing 5.8%All U.S. Not ranked for this question Not ranked for this question Rank Not ranked for this question Not ranked for this question Percentile 3 of 64 filings · FY2023-25

Work visas withdrawn⁠Work visas withdrawnINVAGEN PHARMACEUTICALS, INC = 0.0%: 0 of its 64 work-visa filings withdrawn, FY2023-25.Manufacturing = 1.1%: all Manufacturing employers' work-visa filings withdrawn, over all their work-visa filings, FY2023-25 (pooled).All U.S. = 1.7%: every U.S. employer's work-visa filings withdrawn, over all their work-visa filings, FY2023-25 (pooled).Rank and percentile: its share among employers with 20+ work-visa filings in FY2023-25, in its industry and in the U.S. — Not ranked for this question.Source: DOL LCA disclosure data, case statusOfficial source ↗ 0.0%INVAGEN PHARMACEUTICALS, INC 1.1%Manufacturing 1.7%All U.S. Not ranked for this question Not ranked for this question Rank Not ranked for this question Not ranked for this question Percentile 0 of 64 filings · FY2023-25

Green cards withdrawn⁠Green cards withdrawnINVAGEN PHARMACEUTICALS, INC = 0.0%: 0 of its 4 green-card filings withdrawn, FY2023-25.Manufacturing = 4.7%: all Manufacturing employers' green-card filings withdrawn, over all their green-card filings, FY2023-25 (pooled).All U.S. = 4.3%: every U.S. employer's green-card filings withdrawn, over all their green-card filings, FY2023-25 (pooled).Rank and percentile: its share among employers with 20+ green-card filings in FY2023-25, in its industry and in the U.S. — Not ranked for this question.Source: DOL PERM disclosure dataOfficial source ↗ 0.0%INVAGEN PHARMACEUTICALS, INC 4.7%Manufacturing 4.3%All U.S. Not ranked for this question Not ranked for this question Rank Not ranked for this question Not ranked for this question Percentile 0 of 4 filings · FY2023-25

Work-visa filings, FY2025 vs FY2024⁠Work-visa filings, FY2025 vs FY2024INVAGEN PHARMACEUTICALS, INC = +80%: its work-visa filings, FY2025 (36) against FY2024 (20).Manufacturing = +17%: all Manufacturing employers' work-visa filings, FY2025 against FY2024 (pooled).All U.S. = +8%: every U.S. employer's work-visa filings, FY2025 against FY2024 (pooled).Rank and percentile: its change among employers with 20+ work-visa filings in both FY2024 and FY2025, in its industry and in the U.S. — Tied #14 with 1 other of 272 in Manufacturing · Tied #185 with 3 others of 2,839 in U.S..Source: DOL disclosure dataOfficial source ↗ +80%INVAGEN PHARMACEUTICALS, INC +17%Manufacturing +8%All U.S. Tied #14 with 1 other of 272 in Manufacturing Tied #185 with 3 others of 2,839 in U.S. Rank Top 6% of Manufacturing Top 7% of U.S. Percentile 36 vs 20 filings · FY2025 vs FY2024

Work-visa filings per 100 employees⁠Work-visa filings per 100 employeesINVAGEN PHARMACEUTICALS, INC = 7.0: each year's work-visa filings over that year's reported headcount, per 100 employees, mean of 2 years, FY2024 and FY2025; FY2025 alone: 11.Manufacturing = 1.3: the median of 623 ranked Manufacturing employers' rates, per 100 employees.All U.S. = 4.8: the median of 5,111 ranked U.S. employers' rates, per 100 employees.Rank and percentile: its rate among employers with 20+ filings and a reported headcount, in its industry and in the U.S. — #91 of 623 in Manufacturing · #2,274 of 5,111 in U.S..Source: DOL filings vs self-reported headcountOfficial source ↗ 7.0INVAGEN PHARMACEUTICALS, INC 1.3Manufacturing 4.8All U.S. #91 of 623 in Manufacturing #2,274 of 5,111 in U.S. Rank Top 15% of Manufacturing Top 45% of U.S. Percentile 64 filings · mean of 2 years, FY2024 and FY2025 · last filing FY2026

Green-card filings, FY2025 vs FY2024⁠Green-card filings, FY2025 vs FY2024INVAGEN PHARMACEUTICALS, INC = 0%: its green-card filings, FY2025 (2) against FY2024 (2).Manufacturing = +74%: all Manufacturing employers' green-card filings, FY2025 against FY2024 (pooled).All U.S. = +60%: every U.S. employer's green-card filings, FY2025 against FY2024 (pooled).Rank and percentile: its change among employers with 20+ green-card filings in both FY2024 and FY2025, in its industry and in the U.S. — Not ranked: under 20 filings in FY2024 or FY2025 (2 and 2).Source: DOL disclosure dataOfficial source ↗ 0%INVAGEN PHARMACEUTICALS, INC +74%Manufacturing +60%All U.S. Not ranked: under 20 filings in FY2024 or FY2025 (2 and 2) Not ranked: under 20 filings in FY2024 or FY2025 (2 and 2) Rank Not ranked: under 20 filings in FY2024 or FY2025 (2 and 2) Not ranked: under 20 filings in FY2024 or FY2025 (2 and 2) Percentile 2 vs 2 filings · FY2025 vs FY2024

Green-card filings per 100 employees⁠Green-card filings per 100 employeesINVAGEN PHARMACEUTICALS, INC = —: 4 green-card filings in FY2023-25 and no per-employee rate (4 green-card filings in FY2023-FY2025, under the 20-filing floor).Manufacturing = 0.69: the median of 247 ranked Manufacturing employers' rates, per 100 employees.All U.S. = 1.9: the median of 1,693 ranked U.S. employers' rates, per 100 employees.Rank and percentile: its rate among employers with 20+ filings and a reported headcount, in its industry and in the U.S. — Not ranked: 4 green-card filings in FY2023-FY2025, under the 20-filing floor.Source: DOL filings vs self-reported headcountOfficial source ↗ —INVAGEN PHARMACEUTICALS, INC 0.69Manufacturing 1.9All U.S. Not ranked: 4 green-card filings in FY2023-FY2025, under the 20-filing floor Not ranked: 4 green-card filings in FY2023-FY2025, under the 20-filing floor Rank Not ranked: 4 green-card filings in FY2023-FY2025, under the 20-filing floor Not ranked: 4 green-card filings in FY2023-FY2025, under the 20-filing floor Percentile 4 filings · FY2023-25 · last filing FY2026

Temp-to-perm⁠Temp-to-permINVAGEN PHARMACEUTICALS, INC = 6.6:1: its 472 work-visa filings over its 71 green-card filings, FY2008–FY2026.Manufacturing = 2.8:1: all Manufacturing employers' work-visa filings over their green-card filings, all years (pooled).All U.S. = 5.4:1: every U.S. employer's work-visa filings over their green-card filings, all years (pooled).Rank and percentile: its ratio among employers with 20+ green-card filings, in its industry and in the U.S.; #1 is the lowest ratio — #1,087 of 1,182 in Manufacturing · #6,662 of 9,248 in U.S..Source: DOL disclosure dataOfficial source ↗ 6.6:1INVAGEN PHARMACEUTICALS, INC 2.8:1Manufacturing 5.4:1All U.S. #1,087 of 1,182 in Manufacturing #6,662 of 9,248 in U.S. Rank Bottom 9% of Manufacturing Bottom 28% of U.S. Percentile 472 work visas / 71 green cards · FY2008–FY2026

Median wage, Chemists⁠Median wage, ChemistsINVAGEN PHARMACEUTICALS, INC = $75,639: the median annual prevailing wage of its green-card filings for Chemists (19-2031), FY2008–FY2026.Manufacturing = $75,878: the median of every Manufacturing employer's green-card filings for the same occupation, all years (pooled).All U.S. = $73,195: the median of every U.S. employer's green-card filings for the same occupation, all years (pooled).Rank and percentile: its median among employers with 20+ green-card filings for this occupation, in its industry and in the U.S.; #1 is the highest pay — Too few U.S. employers to rank (16).Source: DOL prevailing-wage data · FY2008–FY2026Official source ↗ $75,639INVAGEN PHARMACEUTICALS, INC $75,878Manufacturing $73,195All U.S. Too few Manufacturing employers to rank (12) Too few U.S. employers to rank (16) Rank Too few Manufacturing employers to rank (12) Too few U.S. employers to rank (16) Percentile 42 filings with a prevailing wage · FY2008–FY2026
CSV export below
History, not a hiring promise.

Every measurement we computed

The same for every question above, so it is shown once here. Ranks count filings, never opinions; each card names what it counted and the group it was ranked against.

0.0% Work visas denied⁠Work visas deniedINVAGEN PHARMACEUTICALS, INC = 0.0%: 0 of its 64 work-visa filings denied, FY2023-25.Manufacturing = 0.2%: all Manufacturing employers' work-visa filings denied, over all their work-visa filings, FY2023-25 (pooled).All U.S. = 0.7%: every U.S. employer's work-visa filings denied, over all their work-visa filings, FY2023-25 (pooled).Rank and percentile: its share among employers with 20+ work-visa filings in FY2023-25, in its industry and in the U.S. — Tied #1 with 705 others of 841 in Manufacturing · Tied #1 with 8,462 others of 9,738 in U.S..Source: DOL LCA disclosure data, case statusOfficial source ↗ 0 of 64 filings · FY2023-25

0.0% Green cards denied⁠Green cards deniedINVAGEN PHARMACEUTICALS, INC = 0.0%: 0 of its 4 green-card filings denied, FY2023-25.Manufacturing = 2.2%: all Manufacturing employers' green-card filings denied, over all their green-card filings, FY2023-25 (pooled).All U.S. = 4.1%: every U.S. employer's green-card filings denied, over all their green-card filings, FY2023-25 (pooled).Rank and percentile: its share among employers with 20+ green-card filings in FY2023-25, in its industry and in the U.S. — Not ranked: under 20 filings (4).Source: DOL PERM disclosure dataOfficial source ↗ 0 of 4 filings · FY2023-25

95.3% Work visas certified⁠Work visas certifiedINVAGEN PHARMACEUTICALS, INC = 95.3%: 61 of its 64 work-visa filings certified, FY2023-25.Manufacturing = 93.4%: all Manufacturing employers' work-visa filings certified, over all their work-visa filings, FY2023-25 (pooled).All U.S. = 91.9%: every U.S. employer's work-visa filings certified, over all their work-visa filings, FY2023-25 (pooled).Rank and percentile: its share among employers with 20+ work-visa filings in FY2023-25, in its industry and in the U.S. — #429 of 841 in Manufacturing · Tied #5,176 with 3 others of 9,738 in U.S..Source: DOL LCA disclosure data, case statusOfficial source ↗ 61 of 64 filings · FY2023-25

100.0% Green cards certified⁠Green cards certifiedINVAGEN PHARMACEUTICALS, INC = 100.0%: 4 of its 4 green-card filings certified, FY2023-25.Manufacturing = 93.2%: all Manufacturing employers' green-card filings certified, over all their green-card filings, FY2023-25 (pooled).All U.S. = 91.6%: every U.S. employer's green-card filings certified, over all their green-card filings, FY2023-25 (pooled).Rank and percentile: its share among employers with 20+ green-card filings in FY2023-25, in its industry and in the U.S. — Not ranked: under 20 filings (4).Source: DOL PERM disclosure dataOfficial source ↗ 4 of 4 filings · FY2023-25

4.7% Work visas certified, then withdrawn⁠Work visas certified, then withdrawnINVAGEN PHARMACEUTICALS, INC = 4.7%: 3 of its 64 work-visa filings certified, then withdrawn, FY2023-25.Manufacturing = 5.2%: all Manufacturing employers' work-visa filings certified, then withdrawn, over all their work-visa filings, FY2023-25 (pooled).All U.S. = 5.8%: every U.S. employer's work-visa filings certified, then withdrawn, over all their work-visa filings, FY2023-25 (pooled).Rank and percentile: its share among employers with 20+ work-visa filings in FY2023-25, in its industry and in the U.S. — Not ranked for this question.Source: DOL LCA disclosure data, case statusOfficial source ↗ 3 of 64 filings · FY2023-25

0.0% Work visas withdrawn⁠Work visas withdrawnINVAGEN PHARMACEUTICALS, INC = 0.0%: 0 of its 64 work-visa filings withdrawn, FY2023-25.Manufacturing = 1.1%: all Manufacturing employers' work-visa filings withdrawn, over all their work-visa filings, FY2023-25 (pooled).All U.S. = 1.7%: every U.S. employer's work-visa filings withdrawn, over all their work-visa filings, FY2023-25 (pooled).Rank and percentile: its share among employers with 20+ work-visa filings in FY2023-25, in its industry and in the U.S. — Not ranked for this question.Source: DOL LCA disclosure data, case statusOfficial source ↗ 0 of 64 filings · FY2023-25

0.0% Green cards withdrawn⁠Green cards withdrawnINVAGEN PHARMACEUTICALS, INC = 0.0%: 0 of its 4 green-card filings withdrawn, FY2023-25.Manufacturing = 4.7%: all Manufacturing employers' green-card filings withdrawn, over all their green-card filings, FY2023-25 (pooled).All U.S. = 4.3%: every U.S. employer's green-card filings withdrawn, over all their green-card filings, FY2023-25 (pooled).Rank and percentile: its share among employers with 20+ green-card filings in FY2023-25, in its industry and in the U.S. — Not ranked for this question.Source: DOL PERM disclosure dataOfficial source ↗ 0 of 4 filings · FY2023-25

543 Green-card + work-visa filings⁠Green-card + work-visa filingsNo percentile or rank — we rank green-card and work-visa filings per employee separatelyNo share — the combined total is all of this employer's filings, so it is not a share of themSource: DOL disclosure dataOfficial source ↗ FY2008–FY2026 filings

+80% Work-visa filings, FY2025 vs FY2024⁠Work-visa filings, FY2025 vs FY2024INVAGEN PHARMACEUTICALS, INC = +80%: its work-visa filings, FY2025 (36) against FY2024 (20).Manufacturing = +17%: all Manufacturing employers' work-visa filings, FY2025 against FY2024 (pooled).All U.S. = +8%: every U.S. employer's work-visa filings, FY2025 against FY2024 (pooled).Rank and percentile: its change among employers with 20+ work-visa filings in both FY2024 and FY2025, in its industry and in the U.S. — Tied #14 with 1 other of 272 in Manufacturing · Tied #185 with 3 others of 2,839 in U.S..Source: DOL disclosure dataOfficial source ↗ 36 vs 20 filings · FY2025 vs FY2024

7.0 Work-visa filings per 100 employees⁠Work-visa filings per 100 employeesINVAGEN PHARMACEUTICALS, INC = 7.0: each year's work-visa filings over that year's reported headcount, per 100 employees, mean of 2 years, FY2024 and FY2025; FY2025 alone: 11.Manufacturing = 1.3: the median of 623 ranked Manufacturing employers' rates, per 100 employees.All U.S. = 4.8: the median of 5,111 ranked U.S. employers' rates, per 100 employees.Rank and percentile: its rate among employers with 20+ filings and a reported headcount, in its industry and in the U.S. — #91 of 623 in Manufacturing · #2,274 of 5,111 in U.S..Source: DOL filings vs self-reported headcountOfficial source ↗ 64 filings · mean of 2 years, FY2024 and FY2025 · last filing FY2026

0% Green-card filings, FY2025 vs FY2024⁠Green-card filings, FY2025 vs FY2024INVAGEN PHARMACEUTICALS, INC = 0%: its green-card filings, FY2025 (2) against FY2024 (2).Manufacturing = +74%: all Manufacturing employers' green-card filings, FY2025 against FY2024 (pooled).All U.S. = +60%: every U.S. employer's green-card filings, FY2025 against FY2024 (pooled).Rank and percentile: its change among employers with 20+ green-card filings in both FY2024 and FY2025, in its industry and in the U.S. — Not ranked: under 20 filings in FY2024 or FY2025 (2 and 2).Source: DOL disclosure dataOfficial source ↗ 2 vs 2 filings · FY2025 vs FY2024

— Green-card filings per 100 employees⁠Green-card filings per 100 employeesINVAGEN PHARMACEUTICALS, INC = —: 4 green-card filings in FY2023-25 and no per-employee rate (4 green-card filings in FY2023-FY2025, under the 20-filing floor).Manufacturing = 0.69: the median of 247 ranked Manufacturing employers' rates, per 100 employees.All U.S. = 1.9: the median of 1,693 ranked U.S. employers' rates, per 100 employees.Rank and percentile: its rate among employers with 20+ filings and a reported headcount, in its industry and in the U.S. — Not ranked: 4 green-card filings in FY2023-FY2025, under the 20-filing floor.Source: DOL filings vs self-reported headcountOfficial source ↗ 4 filings · FY2023-25 · last filing FY2026

Public record data. PERM PERM — Permanent Employment Certification (ETA-9089) Employer's DOL filing to sponsor a specific worker for an employment-based green card after testing the U.S. job marketTemporary visa (often F-1 student → H-1B)PERM — employer asks DOL to certify the job (you are here)I-140 — employer petitions USCISPriority-date wait (varies by country of birth — years to decades)Green card (I-485 / consular)DOL certifies paperwork — it does not issue green cards; per-position; certified ≠ granted. NEVER "work permit"Common path — some categories skip PERM (EB-1, NIW); timelines vary widely by country of birth. Educational info, not legal advice.Official source ↗ and LCA LCA — Labor Condition Application (ETA-9035) Employer's legally binding wage promise to DOL, required before employing H-1B/H-1B1/E-3 workersJob offer + prevailing wageLCA — wage promise to DOL (you are here)Cap lottery registration (USCIS)I-129 petition (USCIS)Visa issued / status changed (DOS or USCIS)One filing can cover MANY positions — filing counts ≠ worker counts (employers over-file for lottery/relocations); not a visaCommon path — some categories skip PERM (EB-1, NIW); timelines vary widely by country of birth. Educational info, not legal advice.Official source ↗ filing data sourced from U.S. Department of Labor OFLC disclosure files. Methodology →

70 Certified green-card filings certified · FY2008–FY2026

0 Denied 0.0% rate · FY2008–FY2026

1 Withdrawn 1.4% rate · FY2008–FY2026

Filings over time

How many green-card filings INVAGEN PHARMACEUTICALS, INC has filed each quarter, from FY2008 to today.

What this means

INVAGEN PHARMACEUTICALS, INC applied to sponsor 71 workers for green cards between 2008 and 2026. A green card application is what an employer files to help a worker stay in the U.S. permanently.

Important: everything on this page is derived from public U.S. Department of Labor records. It is not a statement of fraud, wrongdoing, or hiring intent. It describes observable filing patterns only.

Offered wages on this employer’s filings

Median annual wage this employer offered, by occupation and fiscal year, over its own PERM PERM — Permanent Employment Certification (ETA-9089) Employer's DOL filing to sponsor a specific worker for an employment-based green card after testing the U.S. job marketTemporary visa (often F-1 student → H-1B)PERM — employer asks DOL to certify the job (you are here)I-140 — employer petitions USCISPriority-date wait (varies by country of birth — years to decades)Green card (I-485 / consular)DOL certifies paperwork — it does not issue green cards; per-position; certified ≠ granted. NEVER "work permit"Common path — some categories skip PERM (EB-1, NIW); timelines vary widely by country of birth. Educational info, not legal advice.Official source ↗ filings — beside the prevailing wage the U.S. Department of Labor determined on the same filings. Two separate figures, never a ratio. Hourly, weekly, bi-weekly and monthly wages are converted to an annual figure using the unit DOL printed for that wage. Methodology →

2 further roles in this employer’s most recent complete year are not shown: fewer than five filings per role, which is too few to publish a wage without describing individual people.

Median offered and prevailing annual wages by occupation and fiscal year. Sortable by occupation, fiscal year and filing count only.
Occupation	Fiscal year	Green-card filings	Median offered	Median prevailing	Wage level
Chemists 19-2031	FY2016	17	$86,000median of 17 filings	$85,696median of 17 filings	Level IV
Chemists 19-2031	FY2015	16	$59,250median of 16 filings	$57,959median of 16 filings	Level I
Chemists 19-2031.00	FY2011	6	$61,000median of 6 filings	$60,923median of 6 filings	Level II

“Not reported” means the Department of Labor published no such figure on those filings — from FY2025 its PERM PERM — Permanent Employment Certification (ETA-9089) Employer's DOL filing to sponsor a specific worker for an employment-based green card after testing the U.S. job marketTemporary visa (often F-1 student → H-1B)PERM — employer asks DOL to certify the job (you are here)I-140 — employer petitions USCISPriority-date wait (varies by country of birth — years to decades)Green card (I-485 / consular)DOL certifies paperwork — it does not issue green cards; per-position; certified ≠ granted. NEVER "work permit"Common path — some categories skip PERM (EB-1, NIW); timelines vary widely by country of birth. Educational info, not legal advice.Official source ↗ disclosure file carries the employer’s offered wage only, with no prevailing-wage determination and no wage level. It does not mean the figure is unknown to us; it means DOL did not publish one.

Wage & Hour Enforcement

Source: DOL Wage & Hour Division WHISARD concluded compliance actions since FY2005. Back wages, civil money penalties, and employees affected, broken down by statute (FLSA, H-1B H-1B — H-1B Specialty Occupation Temporary employer-sponsored visa for degree-level specialty roles; 85K annual cap via lotteryJob offer + prevailing wageLCA — wage promise to DOLCap lottery registration (USCIS)I-129 petition (USCIS)Visa issued / status changed (DOS or USCIS) (you are here)Nonimmigrant/temporary — never "immigrant worker"Common path — some categories skip PERM (EB-1, NIW); timelines vary widely by country of birth. Educational info, not legal advice.Official source ↗ , H-2A, H-2B, SCA, Davis-Bacon, FMLA). Data mirrored nightly from the WHISARD dataset.

No concluded Back wages Back wages — Wage & Hour Division FLSA findings Money owed to workers after a DOL wage-and-hour investigation or settlementCivil, not criminal; includes settlements + PAID self-reports; back wages ≠ fines. Use this label rather than the colloquial criminal-sounding one (§3)Official source ↗ enforcement actions found for this employer in the WHISARD dataset (FY2005-present).

USCIS H-1B petition outcomes

Source: USCIS USCIS — U.S. Citizenship and Immigration Services Reviews petitions and grants immigration statusNot ICE/CBPOfficial source ↗ H-1B H-1B — H-1B Specialty Occupation Temporary employer-sponsored visa for degree-level specialty roles; 85K annual cap via lotteryJob offer + prevailing wageLCA — wage promise to DOLCap lottery registration (USCIS)I-129 petition (USCIS)Visa issued / status changed (DOS or USCIS) (you are here)Nonimmigrant/temporary — never "immigrant worker"Common path — some categories skip PERM (EB-1, NIW); timelines vary widely by country of birth. Educational info, not legal advice.Official source ↗ Employer Data Hub. Petition decisions by fiscal year.

H-1B petition decisions as a share of certified work-visa filings

24.6%

118 decisions / 479 certified LCAs

Total USCIS USCIS — U.S. Citizenship and Immigration Services Reviews petitions and grants immigration statusNot ICE/CBPOfficial source ↗ decisions

118

116 initial approvals, 2 initial denials

Worker retention pattern

0.16:1

initial approvals per continuing approval, USCIS USCIS — U.S. Citizenship and Immigration Services Reviews petitions and grants immigration statusNot ICE/CBPOfficial source ↗ H-1B H-1B — H-1B Specialty Occupation Temporary employer-sponsored visa for degree-level specialty roles; 85K annual cap via lotteryJob offer + prevailing wageLCA — wage promise to DOLCap lottery registration (USCIS)I-129 petition (USCIS)Visa issued / status changed (DOS or USCIS)Nonimmigrant/temporary — never "immigrant worker"Common path — some categories skip PERM (EB-1, NIW); timelines vary widely by country of birth. Educational info, not legal advice.Official source ↗ hub, FY2021-FY2023

100.0% initial approval rate: 7 of 7 initial petitions approved, FY2021-FY2023

H-1B petition decisions as a share of certified work-visa filings

24.6%: 118 USCIS USCIS — U.S. Citizenship and Immigration Services Reviews petitions and grants immigration statusNot ICE/CBPOfficial source ↗ H-1B H-1B — H-1B Specialty Occupation Temporary employer-sponsored visa for degree-level specialty roles; 85K annual cap via lotteryJob offer + prevailing wageLCA — wage promise to DOLCap lottery registration (USCIS)I-129 petition (USCIS)Visa issued / status changed (DOS or USCIS) (you are here)Nonimmigrant/temporary — never "immigrant worker"Common path — some categories skip PERM (EB-1, NIW); timelines vary widely by country of birth. Educational info, not legal advice.Official source ↗ petition decisions and 479 certified LCAs, counted separately.

FY	Initial petitions approved	Initial petitions denied	Renewal petitions approved	Renewal petitions denied	Total
2023	0	0	7	1	8
2022	5	0	11	0	16
2021	2	0	27	0	29
2020	3	0	8	1	12
2019	3	0	14	0	17
2018	3	0	18	0	21
2017	1	0	8	0	9
2016	1	0	35	0	36
2015	2	0	6	0	8
2014	7	0	22	0	29
2013	22	1	19	0	42
2012	9	1	8	0	18
2011	27	0	4	0	31
2010	9	0	7	0	16
2009	22	0	4	0	26

15 fiscal years of USCIS USCIS — U.S. Citizenship and Immigration Services Reviews petitions and grants immigration statusNot ICE/CBPOfficial source ↗ H-1B H-1B — H-1B Specialty Occupation Temporary employer-sponsored visa for degree-level specialty roles; 85K annual cap via lotteryJob offer + prevailing wageLCA — wage promise to DOLCap lottery registration (USCIS)I-129 petition (USCIS)Visa issued / status changed (DOS or USCIS) (you are here)Nonimmigrant/temporary — never "immigrant worker"Common path — some categories skip PERM (EB-1, NIW); timelines vary widely by country of birth. Educational info, not legal advice.Official source ↗ petition data. Data from USCIS USCIS — U.S. Citizenship and Immigration Services Reviews petitions and grants immigration statusNot ICE/CBPOfficial source ↗ H-1B H-1B — H-1B Specialty Occupation Temporary employer-sponsored visa for degree-level specialty roles; 85K annual cap via lotteryJob offer + prevailing wageLCA — wage promise to DOLCap lottery registration (USCIS)I-129 petition (USCIS)Visa issued / status changed (DOS or USCIS) (you are here)Nonimmigrant/temporary — never "immigrant worker"Common path — some categories skip PERM (EB-1, NIW); timelines vary widely by country of birth. Educational info, not legal advice.Official source ↗ Employer Data Hub.

Similar employers

Other Manufacturing filers with comparable filing volume.

Filing data sourced from the U.S. Department of Labor's Office of Foreign Labor Certification public disclosure files. Past filings do not predict future hiring behavior. Employers may petition for review at /dispute.

Hire4Real displays public records from the U.S. Department of Labor (PERM Case Disclosure, LCA Disclosure, OEWS prevailing wages) and the U.S. Citizenship and Immigration Services H-1B Employer Data Hub. Hire4Real describes employers, not individuals. Hire4Real is not a consumer reporting agency ("CRA") as defined by the Fair Credit Reporting Act, 15 U.S.C. § 1681 et seq., and its outputs are not "consumer reports." Hire4Real is not a background check service and may not be used to make employment decisions about any individual. Hire4Real is not affiliated with or endorsed by the U.S. Department of Labor, U.S. Citizenship and Immigration Services, or any employer displayed on the site.